Stakeholder Input Sought in Evaluation of FDA Human Foods Program

Public Meeting Registration and Online Stakeholder Portal Now Open

(September 16, 2022) The Reagan-Udall Foundation today opened a Stakeholder Portal to collect perspectives and experiences with FDA’s human foods program. In addition, the Foundation announced a public meeting of its food-focused Independent Expert Panel.

“The Expert Panel wants to hear directly from stakeholders,” said Jane E. Henney, MD, Chair of the foods Independent Expert Panel. “We want to hear firsthand observations about both the strengths and challenges the program faces as well as ideas on how to best prepare for the regulatory landscape of the future.” 

The portal allows all stakeholders to share their insights about what is working in FDA’s human foods program, the challenges it faces, and suggestions to improve program operations. Comments received through the Stakeholder Portal will be shared with the Independent Expert Panel charged with generating the recommendations for FDA. 

On September 29-30, the Reagan-Udall Foundation will facilitate a public meeting of the Independent Expert Panel on food. Invited stakeholders will provide feedback on critical topics such as Nutrition Initiatives, Food Safety, Intra-Federal Relations, Federal-State Relationships, Resources, and Positioning FDA for the Future. A limited number of seats are available to stakeholders who wish to observe the in-person meeting to be held in Washington, DC. To expand access, audio streaming will also be available. 

Launched last week, the operational evaluation focuses on the structure/leadership, authority, resources, and culture of FDA’s human foods program. The 60-business-day review will culminate in recommendations that will be submitted on December 6, 2022, to Dr. Robert Califf, Commissioner of Food and Drugs, at FDA.

About the Reagan-Udall Foundation for the FDA

The Reagan-Udall Foundation for the FDA (FDA Foundation) is an independent 501(c)(3) created by Congress to advance regulatory science to help the U.S. Food and Drug Administration accomplish its mission. The FDA Foundation works to improve health and safety through stakeholder engagement and public-private partnerships that facilitate innovation, foster the use of real-world evidence, and identify modern tools and policies to keep pace with today’s rapidly evolving science.

Media Contacts:

Lea Ann Browning-McNee
301-509-1846 (cell)